Full-Time

Director – NGS & Molecular Assays

24200-U-690-NGS

Confirmed live in the last 24 hours

ArsenalBio

ArsenalBio

201-500 employees

Develops programmable cell therapies for cancer

Biotechnology
Healthcare

Compensation Overview

$194.3k - $238kAnnually

Senior, Expert

San Bruno, CA, USA

Must work onsite in South San Francisco.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • Ph.D. in a life science field with experience in NGS and molecular assay technology development, with 9+ years of relevant work experience and 7+ years of management experience, is preferred. MA/MS: Industry experience 14+ years required, BS/BA: Industry experience 16+ years required.
  • Proven track record of managing high-performing teams of scientists and research associates
  • Strong leadership skills and a demonstrated ability to build and retain an effective team as a proven mentor, coach, motivator, and manager
  • Demonstrated ability to work collaboratively in a cross-functional matrixed environment
  • Deep understanding and experience with NGS platforms
  • Significant direct experience with single-cell sequencing, including 10x Genomics and SPLiT-seq approaches
  • Excellent troubleshooting, organization, and planning skills, and the ability to work under timelines in a fast-paced environment
  • Demonstrated ability to effectively influence senior executives, and the capacity to develop, communicate, advocate for, and execute a scientific strategy
  • Excellent interpersonal, verbal, and written communication skills
  • Ability to credibly represent the company to external constituents, including KOLs, investors, and regulators
  • An outstanding work ethic coupled with an engaging disposition and solid entrepreneurial drive
Responsibilities
  • Lead R&D team effectively to produce a pipeline of both NGS and molecular assays
  • Develop assays to support discovery biology and IND-enabling research activities
  • Provide guidance and technical expertise to all ArsenalBio teams
  • Support product development and regulatory filings for pivotal clinical studies
  • Manage the completion of project deliverables and maintain timelines
  • Manage internal resource allocation and external collaborations
  • Prepare and review sections of INDs, abstracts, manuscripts, presentations, and technical reports
  • Contribute to scientific and strategy discussions to advance and enhance ArsenalBio’s platform and product candidates
  • Manage CROs to implement NGS and molecular biomarker assays to progress ArsenalBio’s programs efficiently to the clinic
  • Manage NGS operations, resources, and budgets

ArsenalBio focuses on developing programmable cell therapies to treat solid tumor cancers. Their approach involves reprogramming cells to enhance their ability to fight cancer. The company is currently in the clinical stage, concentrating on research and development to bring these therapies to market. Unlike many competitors, ArsenalBio emphasizes a diverse team of experts from various scientific and clinical backgrounds, which strengthens their ability to innovate in cancer treatment. The ultimate goal is to provide effective therapies for patients suffering from solid tumor cancers, thereby improving their chances of recovery.

Company Stage

Series C

Total Funding

$612.8M

Headquarters

San Francisco, California

Founded

2019

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

75%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful clinical trials, such as the ongoing Phase 1/2 trial for AB-2100, could lead to breakthrough treatments for solid tumors, significantly impacting patient outcomes.
  • The $220 million Series B financing round and partnerships with major investors like Softbank Vision Fund 2 and Bristol-Myers Squibb provide strong financial backing for continued R&D and clinical advancements.
  • Presentations at high-profile conferences like AACR highlight ArsenalBio's innovative progress and can attract further investment and collaboration opportunities.

What critics are saying

  • As a clinical stage company, ArsenalBio faces the inherent risk of clinical trial failures, which could delay or halt the commercialization of their therapies.
  • The competitive landscape in the biotechnology sector is intense, with numerous companies vying to develop effective cancer treatments, potentially impacting ArsenalBio's market share.

What makes ArsenalBio unique

  • ArsenalBio's focus on programmable cell therapies for solid tumors sets it apart from competitors who primarily target hematological malignancies.
  • The company's proprietary CITE technology and Integrated Circuit T (ICT) cell approach offer a unique method to enhance T cell functionality and overcome tumor microenvironments.
  • Strategic collaborations with industry leaders like Genentech and Thermo Fisher Scientific bolster ArsenalBio's technological capabilities and market positioning.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision coverage

Virtual & telehealth options

Parental leave

Flexible work schedule

Flexible PTO

Mental health resources